Skip to main content

2024 Annual Meeting Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Pradeep Sharma, PhD

Head of Clinical Physiologically-Based Pharmacokinetic (PBPK) Modeling
AstraZeneca plc, United Kingdom

Poster(s):

127: Phase I Open Label Study to Evaluate the Effects of Strong CYP1A2 Inhibitor on Savolitinib Pharmacokinetics in Healthy Volunteers

Monday, September 9, 2024
5:00 PM – 7:00 PM ET